Katalog der Deutschen Nationalbibliothek

Neuigkeiten Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00
 
Neuigkeiten

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

 
 
 


Ergebnis der Suche nach: Placebo
im Bestand: Gesamter Bestand

9391 - 9400 von 9900
<< < > >>


Artikel 9391 The efficacy and safety of 'antianxiety granule' for anxiety disorder: a multicentre, randomized, double-blind, placebo-controlled, parallel-group trial
Enthalten in Trials Bd. 21, 23.1.2020, Nr. 1, date:12.2020: 1-8
Online Ressource
Artikel 9392 The efficacy and safety of Anyu Peibo Capsule in the treatment of patients with major depressive disorder in China: study protocol for a randomized placebo-controlled trial
Enthalten in Trials Bd. 22, 3.9.2021, Nr. 1, date:12.2021: 1-9
Online Ressource
Artikel 9393 The Efficacy and Safety of Blonanserin Compared with Haloperidol in Acute-Phase Schizophrenia
Enthalten in CNS drugs Bd. 23, 29.8.2012, Nr. 7, date:7.2009: 615-625
Online Ressource
Artikel 9394 The efficacy and safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang on Korean patients with cold hypersensitivity in the hands: study protocol for a pilot, double-blind, randomized, placebo-controlled, parallel-group clinical trial
Enthalten in Trials Bd. 18, 8.6.2017, Nr. 1, date:12.2017: 1-8
Online Ressource
Artikel 9395 The efficacy and safety of fluoxetine versus placebo for stroke recovery: a meta-analysis of randomized controlled trials
Enthalten in International journal of clinical pharmacy Bd. 45, 20.4.2023, Nr. 4, date:8.2023: 839-846
Online Ressource
Artikel 9396 The efficacy and safety of herbal medicine BHH10 in postmenopausal women with osteoporosis: study protocol for a phase II, multicenter, randomized, double-blinded, placebo-controlled clinical trial
Enthalten in Trials Bd. 19, 10.9.2018, Nr. 1, date:12.2018: 1-9
Online Ressource
Artikel 9397 The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study
Enthalten in Inflammation research Bd. 70, 29.9.2021, Nr. 10-12, date:12.2021: 1233-1246
Online Ressource
Artikel 9398 The efficacy and safety of Longmu Tang granule for the treatment of atopic dermatitis: study protocol for a single-centred, double-blinded, randomised, placebo-controlled trial
Enthalten in Trials Bd. 23, 9.5.2022, Nr. 1, date:12.2022: 1-11
Online Ressource
Artikel 9399 The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial
Enthalten in GeroScience Bd. 45, 8.12.2022, Nr. 1, date:2.2023: 29-43
Online Ressource
Artikel 9400 The efficacy and safety of Sipjeondaebo-tang in Korean patients with cold hypersensitivity in the hands and feet: a protocol for a pilot, randomized, double-blind, placebo-controlled, parallel-group clinical trial
Enthalten in Trials Bd. 20, 15.4.2019, Nr. 1, date:12.2019: 1-8
Online Ressource


9391 - 9400 von 9900
<< < > >>


E-Mail-IconAdministration